Why Did INBS Stock Jump 11% In Pre-Market Today?
Synopsis
The company announced the first shipment of its Intelligent Fingerprinting Drug Screening Readers, produced in collaboration with Syrma Johari MedTech.
Shares of Intelligent Bio Solutions Inc. (INBS) gained 11% in pre-market trading on Wednesday, after the company announced the rollout of the first shipment of its Intelligent Fingerprinting Drug Screening Readers produced under a new manufacturing partnership with Syrma Johari MedTech.
The medical technology company said its manufacturing capacity is now about four times higher than before. As a result, it expects to reduce annual production costs by more than 40%, which could lift gross margins by around 20 percentage points each year.
The devices are being deployed across construction, transportation, logistics, and manufacturing sectors in the U.K. and Europe. Intelligent Bio Solutions also doubled its in-house production capacity for test strips. The company expects additional shipments in 2026 as it prepares for U.S. market entry.
Get updates to this developing story on Stocktwits.<
For updates and corrections, email newsroom[at]stocktwits[dot]com.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.